| 1 |
Prado CM, Laviano A, Gillis C, Sung AD, Gardner M, Yalcin S, Dixon S, Newman SM, Bastasch MD, Sauer AC, Hegazi R, Chasen MR. Examining Guidelines and New Evidence in Oncology Nutrition: a Position Paper on Gaps and Opportunities in Multimodal Approaches to Improve Patient Care. Komp Nutr Diet 2023. [DOI: 10.1159/000529617] [Reference Citation Analysis]
|
| 2 |
Prado CM, Ford KL, Gonzalez MC, Murnane LC, Gillis C, Wischmeyer PE, Morrison CA, Lobo DN. Nascent to novel methods to evaluate malnutrition and frailty in the surgical patient. JPEN J Parenter Enteral Nutr 2023;47 Suppl 1:S54-68. [PMID: 36468288 DOI: 10.1002/jpen.2420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Muscaritoli M, Bar-Sela G, Battisti NML, Belev B, Contreras-Martínez J, Cortesi E, de Brito-Ashurst I, Prado CM, Ravasco P, Yalcin S. Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO). Cancers (Basel) 2023;15. [PMID: 36672329 DOI: 10.3390/cancers15020380] [Reference Citation Analysis]
|
| 4 |
Sullivan ES, Daly LE, Scannell C, Ní Bhuachalla ÉB, Cushen S, Power DG, Ryan AM. A large, multi-centre prospective study demonstrating high prevalence of malnutrition associated with reduced survival in ambulatory systemic anti-cancer therapy patients. Clin Nutr ESPEN 2022;52:208-17. [PMID: 36513456 DOI: 10.1016/j.clnesp.2022.10.009] [Reference Citation Analysis]
|
| 5 |
Zhang L, Guan J, Ding C, Feng M, Gong L, Guan W. Muscle loss 6 months after surgery predicts poor survival of patients with non-metastatic colorectal cancer. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1047029] [Reference Citation Analysis]
|
| 6 |
Bozzetti F. Evolving concepts on perioperative nutrition of sarcopenic cancer patients. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.10.008] [Reference Citation Analysis]
|
| 7 |
Wan Q, Yuan Q, Zhao R, Shen X, Chen Y, Li T, Song Y. Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study. Front Oncol 2022;12:984459. [DOI: 10.3389/fonc.2022.984459] [Reference Citation Analysis]
|
| 8 |
Vaughan VC, Martin P. Multidisciplinary approaches to cancer cachexia: current service models and future perspectives. Expert Rev Anticancer Ther 2022;:1-13. [PMID: 35699257 DOI: 10.1080/14737140.2022.2088516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Orsso CE, Montes-Ibarra M, Findlay M, van der Meij BS, de van der Schueren MAE, Landi F, Laviano A, Prado CM. Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research. J Cachexia Sarcopenia Muscle 2022;13:1442-59. [PMID: 35301816 DOI: 10.1002/jcsm.12954] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 10 |
Prado CM, Orsso CE, Pereira SL, Atherton PJ, Deutz NEP. Effects of β-hydroxy β-methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review. J Cachexia Sarcopenia Muscle 2022;13:1623-41. [PMID: 35301826 DOI: 10.1002/jcsm.12952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 11 |
Groot OQ, Bongers MER, Buckless CG, Twining PK, Kapoor ND, Janssen SJ, Schwab JH, Torriani M, Bredella MA. Body composition predictors of mortality in patients undergoing surgery for long bone metastases. J Surg Oncol 2022. [PMID: 35023149 DOI: 10.1002/jso.26793] [Reference Citation Analysis]
|
| 12 |
Ford KL, Arends J, Atherton PJ, Engelen MPKJ, Gonçalves TJM, Laviano A, Lobo DN, Phillips SM, Ravasco P, Deutz NEP, Prado CM. The importance of protein sources to support muscle anabolism in cancer: An expert group opinion. Clin Nutr 2022;41:192-201. [PMID: 34891022 DOI: 10.1016/j.clnu.2021.11.032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
|
